Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2–≤4, pT3: >4 cm) is More Valid and Clinically Relevant

Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging

(2015) Olca Basturk et al.   ANNALS OF SURGICAL ONCOLOGY

Whipple Made Simple For Surgical Pathologists

(2014) N. Volkan Adsay et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Survival effect of tumor size and extrapancreatic extension in surgically resected pancreatic cancer: proposal for improved T classification

(2014) Hosub Park et al.   HUMAN PATHOLOGY

Peripancreatic Soft Tissue Involvement: Independent Outcome Predictor in Patients With Resected Pancreatic Adenocarcinoma

(2014) Alireza Hamidian Jahromi et al.   INTERNATIONAL SURGERY

Management of Borderline Resectable Pancreatic Cancer

(2014) Matthew H.G. Katz et al.   SEMINARS IN RADIATION ONCOLOGY

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

(2013) Helmut Oettle et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study

(2013) Marianne Sinn et al.   JOURNAL OF SURGICAL ONCOLOGY

Aggressive Surgery for Borderline Resectable Pancreatic Cancer

(2013) Suguru Yamada et al.   PANCREAS

Ampullary Region Carcinomas

(2012) Volkan Adsay et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Resection margin involvement and tumour origin in pancreatic head cancer

(2012) C. S. Verbeke et al.   BRITISH JOURNAL OF SURGERY

Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure

(2012) Cristina R. Ferrone et al.   SURGERY

An anatomical‐based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment

(2012) Vlad Maksymov et al.   HPB

Pancreatic Cancer Surgery in the New Millennium

(2011) Werner Hartwig et al.   ANNALS OF SURGERY

Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma

(2011) Mechteld C. de Jong et al.   JOURNAL OF SURGICAL ONCOLOGY

Conditional survival in pancreatic cancer: better than expected

(2011) Tara S. Kent et al.   HPB

Prognostic Factors for Survival in Patients With Unresectable Pancreatic Cancer

(2010) Andreas Weber et al.   PANCREAS

The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement

(2010) Günter Klöppel et al.   VIRCHOWS ARCHIV

Redefining resection margin status in pancreatic cancer

(2010) Caroline S. Verbeke et al.   HPB

Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections

(2010) Anna Melissa Schlitter et al.   Cancers

Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Douglas B. Evans et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Factors and Adjuvant Chemoradiation Therapy After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

(2009) Dong Do You et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Most Pancreatic Cancer Resections are R1 Resections

(2008) Irene Esposito et al.   ANNALS OF SURGICAL ONCOLOGY

Resection margins and R1 rates in pancreatic cancer – are we there yet?

(2008) C S Verbeke   HISTOPATHOLOGY

The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment

(2008) N Volkan Adsay et al.   MODERN PATHOLOGY

Prognostic Factors After Resection of Pancreatic Cancer

(2008) Michio Ueda et al.   WORLD JOURNAL OF SURGERY